Approximation to the Consumption of Healthcare Resources and the Economic Cost of SARS-CoV-2 Patient Management: A Retrospective Study.
COVID-19
SARS-CoV-2
coronavirus infections
cost control and cost management
health economics
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
26
12
2021
accepted:
02
02
2022
entrez:
18
4
2022
pubmed:
19
4
2022
medline:
20
4
2022
Statut:
epublish
Résumé
Spain has become one of the countries most affected by coronavirus disease 2019 (COVID-19), with the highest testing rates, and one of the worst-performing countries in the fight against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. There are no studies related to the consumption of health resources and the economic cost of the SARS-CoV-2 virus. We present a retrospective analysis of 9,811 (Primary Care and Hospital) patients which aimed to estimate public health expenditure by the consumption of health resources due to COVID-19. According to the results, the gender distribution of patients has a similar rate in both groups, with slightly higher rates in women. Similarly, age is the same in both groups, with a median of 62 years in the case of hospitalizations and 61 years in the case of primary care; using a weighted average of these rates and costs, we can estimate that the average cost of care per patient infected with the SARS-CoV-2 virus, regardless of the course is €2373.24. We conclude that a patient with COVID-19 without hospitalization costs €729.79, while the expenses of a hospitalized patient are between €4294.36 and €14440.68, if there is ICU admission.
Identifiants
pubmed: 35433597
doi: 10.3389/fpubh.2022.843751
pmc: PMC9008573
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
843751Informations de copyright
Copyright © 2022 Calderón-Moreno, Juárez-Vela, Delgado-Rodríguez, Quintana-Díaz, Magallón-Botaya, Olivan-Blázquez, Cobos-Rincón, Santolalla-Arnedo, Ramírez-Torres, Gea-Caballero and Andrés-Esteban.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int J Environ Res Public Health. 2021 Apr 06;18(7):
pubmed: 33917578
Rev Clin Esp. 2021 Aug-Sep;221(7):400-403
pubmed: 33288965
Gac Sanit. 2021 Jul-Aug;35(4):355-357
pubmed: 32354565
Lancet. 2020 Aug 22;396(10250):529-530
pubmed: 32771082
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Oct;67(8):425-437
pubmed: 32800622
Front Public Health. 2020 Jul 03;8:347
pubmed: 32719765
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35
pubmed: 32232218
Curr Med Res Opin. 2021 Jan;37(1):27-36
pubmed: 33306421